G. O. Breault

442 total citations
10 papers, 351 citations indexed

About

G. O. Breault is a scholar working on Pharmacology, Gastroenterology and Analytical Chemistry. According to data from OpenAlex, G. O. Breault has authored 10 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 2 papers in Gastroenterology and 2 papers in Analytical Chemistry. Recurrent topics in G. O. Breault's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Inflammatory mediators and NSAID effects (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). G. O. Breault is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Inflammatory mediators and NSAID effects (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). G. O. Breault collaborates with scholars based in United States, Switzerland and Belgium. G. O. Breault's co-authors include K.C. Kwan, D E Duggan, F. Gilbert McMahon, S. L. Steelman, Dominick J. Tocco, Anthony G. Zacchei, James A. Totaro, Elwood L. Foltz, Bai‐Lin Lei and Robert L. Davis and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition.

In The Last Decade

G. O. Breault

9 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. O. Breault United States 7 164 102 65 52 48 10 351
Wagner Jg United States 11 89 0.5× 80 0.8× 34 0.5× 77 1.5× 51 1.1× 26 345
Masakazu Hayashibara Japan 12 142 0.9× 170 1.7× 81 1.2× 55 1.1× 39 0.8× 31 393
Joan Moncrieff South Africa 13 137 0.8× 116 1.1× 72 1.1× 52 1.0× 78 1.6× 39 467
A.P. Intoccia United States 8 159 1.0× 42 0.4× 81 1.2× 46 0.9× 57 1.2× 14 438
GW Mihaly Australia 8 98 0.6× 121 1.2× 152 2.3× 78 1.5× 32 0.7× 9 439
P. J. Pentik�inen Finland 8 81 0.5× 73 0.7× 42 0.6× 48 0.9× 70 1.5× 9 379
Berry J. Kline United States 10 90 0.5× 86 0.8× 67 1.0× 56 1.1× 29 0.6× 17 376
G Bozler Germany 9 98 0.6× 58 0.6× 71 1.1× 24 0.5× 39 0.8× 25 345
VA John United Kingdom 11 71 0.4× 74 0.7× 37 0.6× 65 1.3× 74 1.5× 25 346
Janis J. MacKichan United States 12 107 0.7× 71 0.7× 57 0.9× 80 1.5× 72 1.5× 30 435

Countries citing papers authored by G. O. Breault

Since Specialization
Citations

This map shows the geographic impact of G. O. Breault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. O. Breault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. O. Breault more than expected).

Fields of papers citing papers by G. O. Breault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. O. Breault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. O. Breault. The network helps show where G. O. Breault may publish in the future.

Co-authorship network of co-authors of G. O. Breault

This figure shows the co-authorship network connecting the top 25 collaborators of G. O. Breault. A scholar is included among the top collaborators of G. O. Breault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. O. Breault. G. O. Breault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gaver, Robert C., et al.. (1986). Evaluation of two new megestrol acetate tablet formulations in humans. Biopharmaceutics & Drug Disposition. 7(1). 35–46. 4 indexed citations
2.
Yeh, K. C., et al.. (1982). Effect of sustained release on the pharmacokinetic profile of indomethacin in man. Biopharmaceutics & Drug Disposition. 3(3). 219–230. 12 indexed citations
3.
Vickers, S., et al.. (1978). EVALUATION OF SUCCINIMIDOETHYL AND PIVALOYLOXYETHYL ESTERS AS PROGENITORS OF METHYLDOPA IN MAN, RHESUS MONKEY, DOG, AND RAT. Drug Metabolism and Disposition. 6(6). 640–646. 21 indexed citations
4.
Kwan, K.C., G. O. Breault, Robert L. Davis, et al.. (1978). Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man. Journal of Pharmacokinetics and Biopharmaceutics. 6(6). 451–476. 30 indexed citations
5.
Kwan, K.C., et al.. (1976). Pharmacokinetics of methyldopa in man.. Journal of Pharmacology and Experimental Therapeutics. 198(2). 264–277. 55 indexed citations
6.
Kwan, K.C., et al.. (1976). Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man. Journal of Pharmacokinetics and Biopharmaceutics. 4(3). 255–280. 123 indexed citations
7.
Tocco, Dominick J., et al.. (1975). Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 3(6). 453–66. 74 indexed citations
8.
Tocco, Dominick J., et al.. (1975). PHYSIOLOGICAL DISPOSITION AND METABOLISM OF5-(2',4'-DIFLUOROPHENYL)SALICYCLIC ACID,A NEW SALICYLATE. Drug Metabolism and Disposition. 3(6). 453–466. 28 indexed citations
9.
Hartmann, Ieneke J. C., et al.. (1975). Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356). European Journal of Clinical Pharmacology. 9(2-3). 125–129. 1 indexed citations
10.
Sinsheimer, Joseph E. & G. O. Breault. (1971). Chromatographic Determination of Benzoic Acid Derivatives for Application to Metabolism Studies. Journal of Pharmaceutical Sciences. 60(2). 255–257. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026